1. Deubiquitinating enzymes as possible drug targets for schistosomiasis
- Author
-
Vanderlei Rodrigues, Lucas Antonio de Lima Paula, Andressa Barban do Patrocinio, Olinda Mara Brigato, Lizandra Guidi Magalhães, Thales Henrique de Paiva, Renata Guerra-Sá, and Fernanda Janku Cabral
- Subjects
Male ,0301 basic medicine ,Proteasome Endopeptidase Complex ,Movement ,Oviposition ,Veterinary (miscellaneous) ,030231 tropical medicine ,Aminopyridines ,Apoptosis ,Real-Time Polymerase Chain Reaction ,Deubiquitinating enzyme ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Transforming Growth Factor beta ,Drug Discovery ,Gene expression ,Autophagy ,Animals ,Schistosomiasis ,chemistry.chemical_classification ,Life Cycle Stages ,Mice, Inbred BALB C ,Deubiquitinating Enzymes ,biology ,Schistosoma mansoni ,Transforming growth factor beta ,030108 mycology & parasitology ,biology.organism_classification ,Mitochondria ,Cell biology ,Infectious Diseases ,Enzyme ,Gene Expression Regulation ,Proteasome ,chemistry ,Insect Science ,biology.protein ,Female ,Parasitology ,Signal transduction ,TRANSDUÇÃO DE SINAL CELULAR ,Thiocyanates ,Signal Transduction - Abstract
Deubiquitinating enzymes (DUBs) are conserved in Schistosoma mansoni and may be linked to the 26S proteasome. Previous results from our group showed that b-AP15, an inhibitor of the 26S proteasome DUBs UCHL5 and USP14 induced structural and gene expression changes in mature S. mansoni pairs. This work suggests the use of the nonselective DUB inhibitor PR-619 to verify whether these enzymes are potential target proteins for new drug development. Our approach is based on previous studies with DUB inhibitors in mammalian cells that have shown that these enzymes are associated with apoptosis, autophagy and the transforming growth factor beta (TGF-β) signaling pathway. PR-619 inhibited oviposition in parasite pairs in vitro, leading to mitochondrial changes, autophagic body formation, and changes in expression of SmSmad2 and SmUSP9x, which are genes linked to the TGF-β pathway that are responsible for parasite oviposition and SmUCHL5 and SmRpn11 DUB maintenance. Taken together, these results indicate that DUBs may be used as targets for the development of new drugs against schistosomiasis.
- Published
- 2021